Vaccine targeting pancreatic cancer shows promise in new study of clinical trial
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
Experimental vaccine for common cancer shows potential in clinical trial
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
Can mRNA vaccines help in the fight against pancreatic cancer?
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...
Interesting Engineering on MSN3d
New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 years
Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.
Science Friday2d
A Vaccine For Pancreatic Cancer Continues To Show Promise
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...
Personal vaccine may reduce risk of pancreatic cancer returning after surgery, small study finds
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.
Vaccine Shows Promise for Pancreatic Cancer, Study Finds
In a small trial, 8 of 16 patients responded well to the mRNA vaccine The vaccine is personalized, based on each patient’s ...
Could a personalized vaccine help fight pancreatic cancer?
"GMA" examines a preliminary study where a personalized mRNA vaccine showed promise in reducing the risk of pancreatic cancer ...
Experimental vaccine for common cancer shows potential in clinical trial; here’s what we know
A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...